COCO
Colossal Biosciences
Bringing extinct species back to life
AISeries CEst. 202150-200 employeesDallas
Colossal Biosciences is using CRISPR gene editing to de-extinct the woolly mammoth, thylacine (Tasmanian tiger), and dodo. Beyond de-extinction, their breakthroughs in gene editing and cold-weather biology create platform technologies for conservation and medicine.
Total Raised$225M
BOLD CapitalWinklevoss Capital
Founders
B
Ben NovakG
George Church
